OCRELIZUMAB vs ODEVIXIBAT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OCRELIZUMAB vs ODEVIXIBAT: Safety Overview
| Metric | OCRELIZUMAB | ODEVIXIBAT |
|---|---|---|
| Total FAERS Reports | 56,186 | 223 |
| Deaths Reported | 1,406 | 10 |
| Death Rate | 2.5% | 4.5% |
| Hospitalizations | 10,364 | 43 |
| Average Patient Age | 47.2 yrs | 14.3 yrs |
| % Female Patients | 72.5% | 49.4% |
| FDA Approval Date | N/A | Jul 20, 2021 |
| Manufacturer | Genentech, Inc. | Albireo Pharma, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |